Your browser doesn't support javascript.
loading
Cross-Dressing of Multiple Myeloma Cells Mediated by Extracellular Vesicles Conveying MIC and ULBP Ligands Promotes NK Cell Killing.
Vulpis, Elisabetta; Loconte, Luisa; Cassone, Chiara; Antonangeli, Fabrizio; Caracciolo, Giulio; Masuelli, Laura; Fazio, Francesca; Petrucci, Maria Teresa; Fionda, Cinzia; Soriani, Alessandra; Cerboni, Cristina; Cippitelli, Marco; Santoni, Angela; Zingoni, Alessandra.
Afiliação
  • Vulpis E; Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Department of Molecular Medicine, "Sapienza" University of Rome, 00185 Rome, Italy.
  • Loconte L; Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Department of Molecular Medicine, "Sapienza" University of Rome, 00185 Rome, Italy.
  • Cassone C; Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Department of Molecular Medicine, "Sapienza" University of Rome, 00185 Rome, Italy.
  • Antonangeli F; Institute of Molecular Biology and Pathology, National Research Council (CNR), 00185 Rome, Italy.
  • Caracciolo G; Department of Molecular Medicine, "Sapienza" University of Rome, 00161 Rome, Italy.
  • Masuelli L; Department of Experimental Medicine, "Sapienza" University of Rome, 00161 Rome, Italy.
  • Fazio F; Department of Cellular Biotechnologies and Hematology, "Sapienza" University of Rome, 00161 Rome, Italy.
  • Petrucci MT; Department of Cellular Biotechnologies and Hematology, "Sapienza" University of Rome, 00161 Rome, Italy.
  • Fionda C; Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Department of Molecular Medicine, "Sapienza" University of Rome, 00185 Rome, Italy.
  • Soriani A; Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Department of Molecular Medicine, "Sapienza" University of Rome, 00185 Rome, Italy.
  • Cerboni C; Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Department of Molecular Medicine, "Sapienza" University of Rome, 00185 Rome, Italy.
  • Cippitelli M; Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Department of Molecular Medicine, "Sapienza" University of Rome, 00185 Rome, Italy.
  • Santoni A; Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Department of Molecular Medicine, "Sapienza" University of Rome, 00185 Rome, Italy.
  • Zingoni A; IRCCS Neuromed, 86077 Pozzilli, Italy.
Int J Mol Sci ; 24(11)2023 May 30.
Article em En | MEDLINE | ID: mdl-37298418
ABSTRACT
Natural Killer (NK) cells are innate cytotoxic lymphoid cells that play a crucial role in cancer immunosurveillance. NKG2D is an activating receptor that binds to MIC and ULBP molecules typically induced on damaged, transformed, or infected cells. The secretion of NKG2D ligands (NKG2DLs) through protease-mediated cleavage or in an extracellular vesicle (EV) is a mode to control their cell surface expression and a mechanism used by cancer cells to evade NKG2D-mediated immunosurveillance. EVs are emerging as important players in mediating cell-to-cell communication due to their ability to transfer biological material to acceptor cells. Herein, we investigated the spreading of NKG2DLs of both MIC and ULBP molecules through the EV-mediated cross-dressing on multiple myeloma (MM) cells. We focused our attention on two MICA allelic variants, namely MICA*008 and MICA*019, representing the prototype of short and long MICA alleles, respectively, and on ULBP-1, ULBP-2, and ULBP-3. Our findings demonstrate that both ULBP and MICA ligands can be acquired from tumor cells through EVs enhancing NK cell recognition and killing. Moreover, besides MICA, EVs expressing ULBP-1 but not ULBP-2 and 3 were detected in bone marrow aspirates derived from a cohort of MM patients. Our findings shed light on the role of EV-associated MICA allelic variants and ULBP molecules in the modulation of NKG2D-mediated NK cell immunosurveillance in the tumor microenvironment. Moreover, the EV-mediated transfer of NKG2DLs could suggest novel therapeutic approaches based on the usage of engineered nanoparticles aimed at increasing cancer cell immunogenicity.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vesículas Extracelulares / Mieloma Múltiplo Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vesículas Extracelulares / Mieloma Múltiplo Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article